ROCKET PHARMACEUTICALS, INC. (RCKT) › Net IncomeROCKET PHARMACEUTICALS, INC. (RCKT) — Net IncomeAnnual figures by fiscal year, from SEC filings.2014: -$9.53M2015: -$67.98M2016: -$7.57M2017: -$19.58M2018: -$74.52M2019: -$77.27M2020: -$139.70M2021: -$169.07M2022: -$221.86M2023: -$245.59M2024: -$258.75M2025: -$223.12M-$223.12M2014Net Income (USD)2025Fiscal YearNet IncomeChange YoY2025-$223.12M+13.8%2024-$258.75M-5.4%2023-$245.59M-10.7%2022-$221.86M-31.2%2021-$169.07M-21.0%2020-$139.70M-80.8%2019-$77.27M-3.7%2018-$74.52M-280.6%2017-$19.58M-158.5%2016-$7.57M+88.9%2015-$67.98M-613.3%2014-$9.53M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share